Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2012
Date:1/25/2012

PALO ALTO, Calif., Jan. 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting results for the first quarter of fiscal year 2012 with net earnings of $0.79 per diluted share, down 1 percent from the year-ago quarter. Revenues for the quarter were $625 million, up 8 percent from the year-ago period. Including $48 million in proton therapy backlog, the company ended the first quarter with a $2.5 billion backlog, up 14 percent from the end of the first quarter in fiscal 2011.  

"While we met our guidance for net earnings and revenues, this was a challenging quarter for the company in a variety of ways," said Tim Guertin, president and CEO of Varian Medical Systems.  "We experienced order push outs in our North American oncology business and X-Ray Product orders and sales were hurt by inventory adjustments by our customers in Japan. As anticipated, the gross margin was impacted by a tough year-ago comparison, product mix, and accounting for Scripps proton revenue with zero margin.  Additionally our operating margin was impacted by the dilutive effects of the Calypso acquisition."  

The company ended the first quarter with $606 million in cash and cash equivalents and $188 million of debt.

Oncology SystemsOncology Systems' first quarter revenues totaled $488 million, up 8 percent from the same period of fiscal year 2011.  First-quarter net orders were $485 million, up 6 percent, with a 22 percent increase in international markets offsetting an 11 percent decline in North America versus the comparable year-ago period."Net orders in all international regions were up in solid double digits, comprising nearly 60 percent of the net orders received by this business during the quarter," Guertin said.  "Several orders that we were aiming for in North America during the quarter were pushed out, but we fully expect that w
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Zacks.com announces the list ... Zacks Equity Research analysts discuss the latest news and events ... the blog include the Hewlett-Packard (NYSE: HPQ - Free Report ... Bulkers, Inc. (NYSE: SB - Free Report ), GlaxoSmithKline ... International N.V. (NYSE: FI - Free Report ). ...
(Date:8/21/2014)... 2014  Henry Schein, Inc. (NASDAQ: HSIC ), ... to office-based dental, animal health and medical practitioners, announced today ... September: , September 4, 2014 – Baird 2014 ... 12:50 p.m. ET , September 8, 2014 – ... York , NY at 1:25 p.m. ET ...
(Date:8/21/2014)... 2014  AliveCor, Inc. announced today that ... has granted the company clearance for its ... most common form of cardiac arrhythmia. AliveCor,s ... patients are experiencing AFib through real-time electrocardiogram ... based AliveCor® Heart Monitor, so physicians can ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Henry Schein To Present At Two Investor Conferences In September 2AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
... Oct. 25, 2011 Desert Radiologists has earned Breast ... and is the first facility in Las Vegas to ... The accreditation certifies that the breast MRI at Desert ... qualifications, facility equipment, quality control procedures and quality assurance ...
... 2011 Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee ... ("Epix") revealed today the contractual agreements for S1P1 lead ... 2011 in a sealed bid sale.   ... and/or developed as part of License Agreement between Amgen ...
Cached Medicine Technology:Desert Radiologists Earns ACR Breast MRI Accreditation 2Contractual Agreements Revealed for S1P1 Lead Compounds, AMG 369 and AMG 277, Offered for Sale at a December 8, 2011 Sealed Bid Sale 2
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... teaches readers how they can use natural methods to ... years has caught the attention of Shane Michaels, prompting ... a condition that affects the skin, it can still ... from it,” reports Michaels. “The intense itching and pain ...
(Date:8/22/2014)... receptor (EGFR) mutations found in the circulating free tumor ... lung cancer (NSCLC) patients correlates well with the EGFR ... kinase inhibitor (TKI) therapy is approved for EGFR activating ... for determining mutation status is with DNA derived directly ... available. A more abundant and less invasive source of ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Advancements ... for some clinical applications due to their cost-effectiveness, ... emerging innovations in ultrasound, such as the evolution ... expected to keep the market moving throughout 2014 ... mobility can enhance not only the point-of-care (POC) ...
(Date:8/22/2014)... NJ (PRWEB) August 22, 2014 ... leading specialist in Internal Medicine, Geriatrics, Hospice and ... network, CarePoint Health Medical Group. Their system welcomes ... skilled and experienced physicians comprise CarePoint Health Medical ... practices in Hudson County, representing a wide range ...
(Date:8/22/2014)... 22, 2014. A new study of self-awareness ... multiple sclerosis (MS) may be able to improve ... was epublished ahead of print on July 2 ... Hali Griswold, Nancy D. Chiaravalloti & John DeLuca: ... multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness is one,s ability ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... Liquids have set out to warm up chilly Boston bus riders by heating ten bus shelters in ... the following locations: , , , 666 ... 510 Boylston Square @ Clarendon Street , ... @ Huntingdon , , , , ...
... cognition tests, study found , , MONDAY, Jan. 26 (HealthDay News) ... glucose (sugar) levels may be linked to lower brain function, ... with higher levels of hemoglobin A1C (a measure of average ... worse results while doing cognitive tasks that tested memory, speed ...
... months most susceptible, analysis finds , , MONDAY, Jan. 26 (HealthDay ... syndrome (SIDS) in the United States has declined, the rate ... a new study reports. , Such deaths have been most ... to the study, published in the February issue of ...
... ,extreme, winter sports by following these safety tipsROSEMONT, Ill., ... ("x-treme") sports can be a fun way to get ... televised events such as the X Games have led ... racing and jumping, snowboarding, snowmobiling, snow biking, and ice ...
... Brighter smiles await,children in Georgia as the Colgate-Palmolive ... Program to the Smyrna and Marietta Big,Lots stores on ... http://www.newscom.com/cgi-bin/prnh/20011026/BIGLOTSLOGO ) , ... van and its team,of dental professionals will provide free ...
... SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San ... the status of its business.Jim Hitchin, SpectraScience,s CEO, said, ... progress on all business fronts. We understand, however, that ... important to provide our shareholders with a greater level ...
Cached Medicine News:Health News:It's Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids 2Health News:Higher Blood Sugar Could Impair Thinking 2Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 2Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 3Health News:More Accidental Infant Deaths Blamed on Suffocation in Bed 4Health News:'X-Tremely' Dangerous Sports 2Health News:'X-Tremely' Dangerous Sports 3Health News:Colgate's Bright Smiles, Bright Futures Program Brings Free Children's Dental Screenings to Atlanta Area Big Lots Stores 2Health News:SpectraScience Announces Business Update 2Health News:SpectraScience Announces Business Update 3
... is the most common cause ... 5% of pediatric visits and ... under 5 years. ImmunoSTAT! Rotatvirus ... rule in or rule out ...
... delivers 100% specificity and 100% PPV ... With as many as one-fourth ... this assay provides a test & ... detection and treatment while reducing overall ...
Shielding's Wrap-Around Apron is designed for front and back protection. This apron features extra wide shoulders distributing weight over a greater area to reduce fatigue....
Shielding's Velcro Adjustable Apron has two velcro flaps which aid in relieving weight off the shoulders. Its comfortable fit is attained by varying the position of flaps....
Medicine Products: